Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Dr. Reddy’s is among the earliest generic API manufacturers globally for Rivaroxaban API and filed the USDMF in March 2014. 

Dr. Reddy’s process involves a selective and efficient chemical transformations that offer distinctive advantage for quality and manufacturability. The process eliminates the potential impurities formed in the process, and can be robust and safely operated at a commercial scale.

In selected markets, we can also provide the formulated drug product of Rivaroxaban and will support you in all regulatory aspects from filing to registration.

To know more about our Rivaroxaban offerings, read the tech sheet by filling the contact form below. 

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

X

Meet our API experts at the world’s
most expansive pharma platform

Join us at CPhI NA 2022!

17th-19th May, 2022 | PCC, PHL
Schedule a meeting